Skip to main content
. 2024 Jan 11;38(2):1013–1021. doi: 10.1111/jvim.16977

TABLE 2.

Overview of adjunctive treatment for thrombocytopenia for the HC and EACA groups.

Immunosuppressants HC group, N (%) EACA group, N (%)
GC* only 6 (18.2) 8 (36.4)
GC + azathioprine 10 (30.3) 4 (18.2)
GC + cyclosporine 5 (15.2) 4 (18.2)
GC + mycophenolate 8 (24.2) 5 (22.7)
GC + 2 second agents 3 (9.1) 1 (4.5)
No immunosuppressants 1 (3) 0
IVIG or vincristine HC group, N (%) EACA group, N (%)
Vincristine 20 (60.6) 15 (68.2
IVIG 3 (9.1) 0
IVIG + vincristine 6 (18.2) 0
No IVIG or vincristine 4 (12.1) 7 (31.8)

Abbreviation: GC*, glucocorticoid.